Technology for Measuring and Monitoring Treatment Compliance Remotely

Medication non-adherence during clinical trials is an ongoing challenge that can result in insufficient safety and efficacy data. For patients with Parkinson’s disease and other neurological disorders, symptomatology such as forgetfulness compounds traditional obstacles to adherence. Today, sponsors...

Descripción completa

Detalles Bibliográficos
Autores principales: Christie, Richard H., Abbas, Anzar, Koesmahargyo, Vidya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385508/
https://www.ncbi.nlm.nih.gov/pubmed/34151856
http://dx.doi.org/10.3233/JPD-212537
_version_ 1783742107927707648
author Christie, Richard H.
Abbas, Anzar
Koesmahargyo, Vidya
author_facet Christie, Richard H.
Abbas, Anzar
Koesmahargyo, Vidya
author_sort Christie, Richard H.
collection PubMed
description Medication non-adherence during clinical trials is an ongoing challenge that can result in insufficient safety and efficacy data. For patients with Parkinson’s disease and other neurological disorders, symptomatology such as forgetfulness compounds traditional obstacles to adherence. Today, sponsors and clinical study sites can call upon various technology tools that improve adherence by monitoring and confirming dosage in near real-time. These tools have the potential to improve the quality of data gleaned from these studies.
format Online
Article
Text
id pubmed-8385508
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher IOS Press
record_format MEDLINE/PubMed
spelling pubmed-83855082021-09-09 Technology for Measuring and Monitoring Treatment Compliance Remotely Christie, Richard H. Abbas, Anzar Koesmahargyo, Vidya J Parkinsons Dis Review Medication non-adherence during clinical trials is an ongoing challenge that can result in insufficient safety and efficacy data. For patients with Parkinson’s disease and other neurological disorders, symptomatology such as forgetfulness compounds traditional obstacles to adherence. Today, sponsors and clinical study sites can call upon various technology tools that improve adherence by monitoring and confirming dosage in near real-time. These tools have the potential to improve the quality of data gleaned from these studies. IOS Press 2021-07-16 /pmc/articles/PMC8385508/ /pubmed/34151856 http://dx.doi.org/10.3233/JPD-212537 Text en © 2021 – The authors. Published by IOS Press https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) License (https://creativecommons.org/licenses/by-nc/4.0/) , which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Christie, Richard H.
Abbas, Anzar
Koesmahargyo, Vidya
Technology for Measuring and Monitoring Treatment Compliance Remotely
title Technology for Measuring and Monitoring Treatment Compliance Remotely
title_full Technology for Measuring and Monitoring Treatment Compliance Remotely
title_fullStr Technology for Measuring and Monitoring Treatment Compliance Remotely
title_full_unstemmed Technology for Measuring and Monitoring Treatment Compliance Remotely
title_short Technology for Measuring and Monitoring Treatment Compliance Remotely
title_sort technology for measuring and monitoring treatment compliance remotely
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385508/
https://www.ncbi.nlm.nih.gov/pubmed/34151856
http://dx.doi.org/10.3233/JPD-212537
work_keys_str_mv AT christierichardh technologyformeasuringandmonitoringtreatmentcomplianceremotely
AT abbasanzar technologyformeasuringandmonitoringtreatmentcomplianceremotely
AT koesmahargyovidya technologyformeasuringandmonitoringtreatmentcomplianceremotely

Ejemplares similares